FDA Moves to Restrict 7-OH Opioid Products
Pharmacy Times
AUGUST 6, 2025
SHOW MORE The FDA targets 7-hydroxymitragynine, a potent kratom derivative, as a controlled substance due to its opioid-like effects and rising health risks. With this action, the FDA is targeting fake or enhanced types of 7-OH, not the typical kratom leaf itself, which only contains a small amount of 7-OH.
Let's personalize your content